Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

NCT05137054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Scripps Clinic Torrey Pines La Jolla, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Indiana University Health Simon Cancer Center Indianapolis, Indiana, United States
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
View all 42 locations
View Trial Details
Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

NCT06943872

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Uci Health Laguna Hills Laguna Hills, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Scripps Prebys Cancer Center San Diego, California, United States
View all 187 locations
View Trial Details
Recruiting

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

NCT07465835

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • START, Midwest Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering New York, United States
View Trial Details
Recruiting

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

NCT05833724

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Far eastern memorial hospital New Taipei City, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT06953960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Southern California /ID# 272414 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 272447 New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
  • University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
View all 48 locations
View Trial Details

Related conditions